INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

2,768 studies · page 25 of 116

2016 / 12-month randomized, placebo-controlled, double-blind trial

Curcumin supplementation prevented a 6-month cognitive decline seen with placebo, but showed no other differences across cognitive tests in older adults.

A 12-month randomized, placebo-controlled, double-blind study evaluated the effect of 1500 mg/d BiocurcumaxTM versus placebo in 96 community-dwelling older adults. A significant time×treatment interaction was detected for the Montreal Cognitive Assessment (F=3.85, P<0.05), driven by a decline in function in the placebo group at 6 months that was not seen in the curcumin group. No differences between the groups were observed for all other clinical and cognitive measures.

Rainey-Smith SR, Brown BM, Sohrabi HR, et al. Br J Nutr, 2016. PMID 27102361

2016 / Double-blind, placebo-controlled, balanced crossover trial

A single dose of resveratrol acutely increased cerebral vasodilator responsiveness in older adults with type 2 diabetes, with 75 mg showing maximum benefit.

In a balanced crossover trial, 36 adults with type 2 diabetes consumed single doses of synthetic trans-resveratrol (0, 75, 150, and 300 mg) at weekly intervals. CVR to a hypercapnic stimulus was assessed by transcranial Doppler ultrasound before and 45 minutes after treatment. Resveratrol increased CVR in the middle cerebral arteries, with mean within-individual changes from placebo of 13.8 ± 3.5% for 75 mg (P = 0.001), 8.9 ± 3.5% for 150 mg (P = 0.016), and 13.7 ± 3.3% for 300 mg (P < 0.001). Only the 75 mg dose significantly increased CVR in the posterior cerebral arteries (13.2 ± 4.5%, P = 0.016).

Wong RH, Nealon RS, Scholey A, et al. Nutr Metab Cardiovasc Dis, 2016. PMID 27105868

2016 / Randomized, double-blind, placebo-controlled clinical trial

In patients with NAFLD, 12 weeks of ginger supplementation significantly reduced ALT, GGT, inflammatory cytokines, insulin resistance, and hepatic steatosis.

A randomized, double-blind, placebo-controlled pilot trial assigned 44 patients with NAFLD to receive either 2 grams per day of a ginger supplement or an identical placebo for 12 weeks, with both groups advised to follow a modified diet and physical activity program. Compared to placebo, ginger supplementation led to significant reductions in alanine aminotransferase, γ-glutamyl transferase, inflammatory cytokines, insulin resistance index, and hepatic steatosis grade. No significant effect was found on hepatic fibrosis or aspartate aminotransferase.

Rahimlou M, Yari Z, Hekmatdoost A, et al. Hepat Mon, 2016. PMID 27110262

2016 / Multicenter randomized controlled trial

Two-year calorie restriction improved mood, quality of life, and sleep in nonobese adults

In a multisite trial, 218 healthy nonobese adults were randomized to 2 years of 25% calorie restriction or ad libitum intake. The calorie restriction group lost 7.6 kg versus 0.4 kg in controls (P < 0.001). Compared to controls, calorie restriction improved depressive symptoms, tension, general health, and sexual drive at month 24, as well as sleep duration at month 12 (all P < 0.05), with no adverse quality-of-life effects.

Martin CK, Bhapkar M, Pittas AG, et al. JAMA Intern Med, 2016. PMID 27136347

2016 / Randomized controlled trial

Adding flaxseed to lifestyle advice reduced metabolic syndrome prevalence and insulin resistance

A randomized trial assigned 44 patients with metabolic syndrome to lifestyle advice alone or with 30 grams of milled flaxseed daily. Metabolic syndrome rates dropped by 82% in the flaxseed group compared to 50% in controls. The flaxseed group experienced greater reductions in insulin resistance (p < 0.001), body weight, waist circumference, and body mass index, although blood pressure showed no significant alterations.

Yari Z, Rahimlou M, Poustchi H, et al. Phytother Res, 2016. PMID 27151322

2016 / Randomized crossover trial

Elevating colonic propionate decreased striatal anticipatory reward responses to high-energy foods and reduced ad libitum energy intake in healthy men.

Twenty healthy nonobese men completed an fMRI food picture evaluation task after consuming control inulin or inulin-propionate ester in a randomized crossover design. Increasing colonic propionate reduced the blood oxygen level-dependent signal in the caudate and nucleus accumbens, with the caudate reduction driven specifically by a decreased response to high-energy food. These effects were accompanied by lower subjective appeal of high-energy food pictures and reduced ad libitum energy intake, without changes in plasma PYY, GLP-1, glucose, or insulin.

Byrne CS, Chambers ES, Alhabeeb H, et al. Am J Clin Nutr, 2016. PMID 27169834

2016 / Comparative tissue analysis and animal intervention study

Hepatic NAD(+) decline occurred with ageing in humans and mice, and oral nicotinamide riboside corrected NAFLD phenotypes in mice.

Investigators compared hepatic NAD(+) and NAD(+) biosynthesis enzymes in middle-aged and aged mice and patients, and tested the effects of high-fat diet and nicotinamide riboside in DN-NAMPT transgenic mice. Hepatic NAD(+) levels decreased in aged mice and humans, with compromised NAMPT-controlled NAD(+) salvage. Middle-aged DN-NAMPT mice fed normal chow displayed systemic NAD(+) reduction and moderate NAFLD phenotypes, which deteriorated under a high-fat diet. Oral administration of nicotinamide riboside completely corrected these NAFLD phenotypes.

Zhou CC, Yang X, Hua X, et al. Br J Pharmacol, 2016. PMID 27174364

2016 / Randomized controlled trial

Chlorella attenuated serum cholesterol increases during a high-cholesterol challenge in healthy adults.

In a randomized, double-blind, placebo-controlled study, 34 adults consumed 510 mg of cholesterol daily alongside 5 g per day of Chlorella or placebo for 4 weeks. Chlorella supplementation led to significantly smaller increases in total cholesterol (3.5% versus 9.8%, P = 0.037) and LDL-C (1.7% versus 14.3%, P = 0.012) compared to placebo. HDL-C increased by 8.3% with Chlorella versus 3.8% with placebo.

Kim S, Kim J, Lim Y, et al. Nutr J, 2016. PMID 27177615

2016 / Before-and-after intervention study

Vitamin C supplementation in battery manufacturing workers reduced oxidative stress markers and improved antioxidant enzyme levels without altering blood lead.

Thirty-six battery manufacturing workers aged 20-60 years received 500 mg/day of vitamin C tablets for one month. Blood lead levels were not significantly altered following supplementation. However, serum lipid peroxide (-15.56%, p<0.001) and serum nitrite (-21.37%, p<0.001) decreased significantly, while erythrocyte superoxide dismutase (38.02%, p<0.001) and catalase (32.36%, p<0.001) increased significantly.

Ghanwat G, Patil AJ, Patil J, et al. J Clin Diagn Res, 2016. PMID 27190789

2016 / Randomized controlled trial

Acute morning and evening blue-enriched light exposure increased insulin resistance and reduced sleepiness in healthy adults.

Nineteen healthy adults completed a 4-day inpatient protocol under dim light conditions and were randomized to 3 hours of blue-enriched light exposure either 0.5 hours after waking (n=9) or 10.5 hours after waking (n=10) on Day 3, with Day 2 serving as baseline. In both groups, insulin total area, HOMA-IR, and HOMA-IR AUC were increased, and subjective sleepiness was reduced with blue-enriched light compared to dim light. The evening group, but not the morning group, exhibited a significantly higher peak glucose value during blue-enriched light exposure compared to dim light. There were no other significant differences between morning and evening groups in response to blue-enriched light.

Cheung IN, Zee PC, Shalman D, et al. PLoS One, 2016. PMID 27191727

2016 / Retrospective analysis of a dietary intervention study

Daily white button mushroom intake for 16 weeks improved select antioxidant and anti-inflammatory markers in adults with metabolic syndrome.

Researchers retrospectively analyzed data from 37 adults with metabolic syndrome who consumed 100 g of white button mushrooms daily for 16 weeks, followed by a one-month mushroom-free period. At 16 weeks, participants showed a doubling of serum ergothioneine, increases in ORAC and adiponectin, and significant decreases in carboxymethyllysine (CML) and methylglyoxal (MG). No changes were observed in 8-isoprostane, leptin, or measures of insulin resistance or glucose metabolism. The authors noted that well-controlled studies are needed to confirm these findings.

Calvo MS, Mehrotra A, Beelman RB, et al. Plant Foods Hum Nutr, 2016. PMID 27193019

2016 / Randomized controlled trial

Mycoprotein meals reduced ad libitum energy intake and postprandial insulin in overweight adults.

In two randomized controlled trials, 55 overweight and obese adults consumed test meals containing varying mycoprotein amounts (44 g, 88 g, or 132 g) or isoenergetic chicken. High mycoprotein decreased subsequent ad libitum energy intake by 10% (280 kJ / 67 kcal, P=0.009) relative to chicken. All mycoprotein meals reduced postprandial insulin concentrations (incremental AUC drops of 8%, 12%, and 21%, P=0.004), without altering glucose, GLP-1, PYY, or energy expenditure.

Bottin JH, Swann JR, Cropp E, et al. Br J Nutr, 2016. PMID 27198187

2016 / Comparative laboratory and pharmacokinetic study

Mucuna pruriens extract provided less clinical benefit and a 3.5-fold lower median AUC than levodopa combined with a dopa-decarboxylase inhibitor in PD patients.

Researchers analyzed 25 Mucuna pruriens (MP) samples and tested levodopa pharmacokinetics and motor response in four Parkinson's disease patients comparing MP to levodopa plus a dopa-decarboxylase inhibitor (LD+DDCI). Median levodopa concentration was 5.29% in dried seeds and 5.3% in roasted powder, while boiling reduced levodopa content by up to 70%. In patients, MP extract at a similar levodopa dose provided less clinical benefit and yielded a 3.5-fold lower median AUC compared to LD+DDCI. The authors conclude MP may offer clinical benefit only when its levodopa content is at least 3.5-fold higher than standard LD+DDCI formulations.

Cassani E, Cilia R, Laguna J, et al. J Neurol Sci, 2016. PMID 27206902

2016 / Animal models and preliminary human study

Fasting mimicking diet eased experimental autoimmune encephalomyelitis and showed preliminary safety in humans.

In mouse models of multiple sclerosis, cyclic fasting mimicking diet reduced clinical symptom severity across all animals, completely reversed signs in 20%, and stimulated oligodendrocyte precursor cell regeneration and remyelination. These murine benefits corresponded with higher corticosterone and regulatory T cells alongside reduced inflammatory cells and cytokines. Preliminary human data suggested the diet or a chronic ketogenic diet was safe and feasible in relapsing-remitting multiple sclerosis.

Choi IY, Piccio L, Childress P, et al. Cell Rep, 2016. PMID 27239035

2016 / Randomized crossover trial

Cranberry polyphenol juice dose-dependently improved flow-mediated dilation in healthy men.

In a randomized crossover study with ten healthy men, intake of cranberry juice delivering 409 to 1910 mg total polyphenols led to dose-dependent improvements in flow-mediated dilation from 1 to 8 hours post-consumption. Peak vascular effects occurred at 4 hours with the juice containing 1238 mg total polyphenols. Circulating concentrations of 12 distinct polyphenol metabolites significantly correlated with the flow-mediated dilation increases.

Rodriguez-Mateos A, Feliciano RP, Boeres A, et al. Mol Nutr Food Res, 2016. PMID 27242317

2016 / Randomized controlled trial

A brown rice-based vegan diet led to greater reductions in HbA1c levels compared to a conventional diabetic diet in Korean patients with type 2 diabetes.

Participants with type 2 diabetes were randomly assigned to follow either a vegan diet (n = 46) or a conventional diet recommended by the Korean Diabetes Association 2011 (n = 47) for 12 weeks. Both groups experienced significant reductions in HbA1c, but reductions were larger in the vegan group than in the conventional group (-0.5% vs. -0.2%; p-for-interaction = 0.017). Among participants with high compliance, the reduction difference between groups was larger (-0.9% vs. -0.3%), remaining significant after adjusting for changes in total energy intake or waist circumference. The authors noted that further studies are needed to evaluate the long-term effects of a vegan diet.

Lee YM, Kim SA, Lee IK, et al. PLoS One, 2016. PMID 27253526

2016 / Randomized double-blind placebo-controlled clinical trial

Melissa officinalis supplementation significantly reduced LDL and AST levels compared with placebo in patients with borderline hyperlipidemia.

Fifty-eight hyperlipidemic patients were randomly assigned to receive capsules containing 1000 mg of Melissa officinalis leaf powder or placebo capsules three times per day for two months. After supplementation, mean LDL significantly decreased in the M. officinalis group compared with the placebo group (P=0.02), and AST also showed a significant difference between groups (P=0.009). Levels of cholesterol, fasting blood glucose, HDL, triglycerides, creatinine, and ALT showed no significant differences between the two groups after two months (P>=0.05).

Jandaghi P, Noroozi M, Ardalani H, et al. Complement Ther Med, 2016. PMID 27261994

2016 / Dose-escalation feasibility trial

Fasting up to 72 hours around platinum-based chemotherapy was feasible and safe in cancer patients.

Researchers tested dose-escalation of fasting (24, 48, or 72 hours around chemotherapy) in 20 cancer patients receiving platinum-based regimens. Feasibility criteria were met, with fasting-related toxicities limited to grade 2 or lower (most commonly fatigue, headache, and dizziness). Leukocyte DNA damage showed a non-significant reduction in subjects fasting ≥48 hours (p = 0.08), and a non-significant trend toward less grade 3 or 4 neutropenia was observed in the 48 and 72 hour cohorts versus the 24 hour cohort (p = 0.17). IGF-1 levels decreased by 30%, 33%, and 8% in the 24, 48, and 72 hour fasting cohorts, respectively, after the first fasting period.

Dorff TB, Groshen S, Garcia A, et al. BMC Cancer, 2016. PMID 27282289

2016 / Randomized crossover trial

Regular meal patterns increased diet-induced thermogenesis and lowered glucose responses in women

Eleven healthy normal-weight women completed a crossover trial comparing two 14-day isoenergetic diets consumed in regular (6 meals daily) or irregular (3-9 meals daily) patterns. Regular meal timing produced a significantly greater thermic effect of food (P < 0.05) and reduced glucose incremental area under the curve following a test drink and selected meals. Participants also reported lower hunger and greater fullness ratings during the regular intervention.

Alhussain MH, Macdonald IA, Taylor MA Am J Clin Nutr, 2016. PMID 27305952

2016 / Randomised controlled cross-over trial

A high-fat meal with Cheddar cheese significantly lowered postprandial C-reactive protein iAUC compared with a vegan alternative.

A randomized controlled cross-over trial in 20 overweight or obese adults with metabolic abnormalities compared the postprandial effects of two isoenergetic high-fat meals: one with Cheddar cheese and one with a vegan alternative, separated by a 1- to 2-week washout. Postprandial TAG concentrations rose steadily following both meals (P < 0.05) through 6 hours. The incremental AUC (iAUC) for CRP was significantly lower (P < 0.05) following the cheese meal compared with the vegan alternative, though no treatment effect was observed for other inflammatory markers.

NANO counterpoint →

Demmer E, Van Loan MD, Rivera N, et al. J Nutr Sci, 2016. PMID 27313852

2016 / Randomized crossover trial

Severe 24-hour calorie restriction did not alter subsequent appetite or energy intake in men.

Eight overweight or obese men completed a randomized crossover trial comparing 24 hours of severe energy restriction (25% of energy needs) against energy balance (100%). Ad libitum energy intake did not differ between conditions on day 2 (15,251 kJ vs 14,946 kJ; P=0.623), day 3, or both days combined. Aside from higher post-breakfast NEFA, GIP, and fat oxidation, hormonal appetite markers and day 2 appetite ratings remained unchanged.

Clayton DJ, Creese M, Skidmore N, et al. Int J Obes (Lond), 2016. PMID 27339607

2016 / Randomized controlled trial and animal study

Protein restriction and low branched-chain amino acid intake improved markers of metabolic health.

A randomized controlled trial in humans demonstrated that a moderate protein-restricted diet improved markers of metabolic health. In parallel animal experiments, mice provided a diet specifically low in branched-chain amino acids showed improvements in glucose tolerance and body composition comparable to whole protein restriction. These changes operated through distinct metabolic pathways, indicating that dietary amino acid composition directly influences metabolic function.

Fontana L, Cummings NE, Arriola Apelo SI, et al. Cell Rep, 2016. PMID 27346343

2016 / Randomized parallel-group trial and pilot crossover trial

A rosemary and grapefruit extract combination improved skin susceptibility to UV radiation, wrinkles, and elasticity in women with aging signs.

Researchers evaluated the efficacy of an oral combination of rosemary and grapefruit extracts in decreasing UV radiation-induced skin damage and improving signs of aging. In a randomized parallel-group trial of 90 women and a pilot crossover trial of 5 women, treated participants showed decreased skin redness and lipoperoxides following UV exposure, along with improvements in skin wrinkledness and elasticity. No differences were observed between 100 mg and 250 mg doses, indicating a plateau effect starting at 100 mg, with some benefits appearing as early as 2 weeks.

Nobile V, Michelotti A, Cestone E, et al. Food Nutr Res, 2016. PMID 27374032

2016 / Inpatient sequential-diet feeding study

An isocaloric ketogenic diet minimally increased energy expenditure without accelerating fat loss.

Seventeen overweight or obese men resided in metabolic wards and consumed a high-carbohydrate diet for four weeks, followed by four weeks on an isocaloric ketogenic diet. Chamber energy expenditure increased by 57 ± 13 kcal/d (P = 0.0004) and doubly labeled water expenditure rose by 151 ± 63 kcal/d (P = 0.03). However, loss of body fat slowed, and participants lost fat-free mass alongside higher protein utilization.

Hall KD, Chen KY, Guo J, et al. Am J Clin Nutr, 2016. PMID 27385608